APA (7th ed.) Citation

P, N., M, F., W, B., C, J., N, D., C, S., . . . M, E. (2023). A rapid, non-invasive, clinical surveillance for CachExia, sarcopenia, portal hypertension, and hepatocellular carcinoma in end-stage liver disease: The ACCESS-ESLD study protocol. BMC gastroenterology, 23(1), 454. https://doi.org/10.1186/s12876-023-03093-8

Chicago Style (17th ed.) Citation

P, Nasr, et al. "A Rapid, Non-invasive, Clinical Surveillance for CachExia, Sarcopenia, Portal Hypertension, and Hepatocellular Carcinoma in End-stage Liver Disease: The ACCESS-ESLD Study Protocol." BMC Gastroenterology 23, no. 1 (2023): 454. https://doi.org/10.1186/s12876-023-03093-8.

MLA (9th ed.) Citation

P, Nasr, et al. "A Rapid, Non-invasive, Clinical Surveillance for CachExia, Sarcopenia, Portal Hypertension, and Hepatocellular Carcinoma in End-stage Liver Disease: The ACCESS-ESLD Study Protocol." BMC Gastroenterology, vol. 23, no. 1, 2023, p. 454, https://doi.org/10.1186/s12876-023-03093-8.